BioCentury | Jun 22, 2018
Financial News
Qiming leads series B for cancer play WindMIL
...led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners Nexus and the Kinneret Group...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
